Abstract
Muscle weakness and low muscle endurance are the primary clinical features of the inflammatory myopathies, myositis. Most patients with polymyositis and dermatomyositis respond to medical treatment, but few recover former muscle function. Patients with inclusion body myositis respond poorly to immunosuppressive treatment, and most patients develop progressive muscle weakness. Different mechanisms that cause impaired muscle performance are involved in different subsets of myositis and in different phases of disease. Muscle fiber degeneration and muscle atrophy, as well as an acquired metabolic myopathy, are likely to contribute. In this context, physical exercise is of importance; however, historically patients with myositis have been discouraged from exercising due to the notion that it might be harmful and cause increased muscle inflammation, but importantly, there are no studies or reports supporting this notion. On the contrary, since 1993, a number of studies have reported both efficacy and safety of different kinds of exercise regimens in patients with chronic as well as recent-onset adult polymyositis and dermatomyositis. In addition, exercise may even reduce muscle inflammation. For inclusion body myositis, exercise data are scarce and the effects less convincing on muscle performance. Children with juvenile dermatomyositis, with chronic as well as active disease, tolerate maximal oxygen uptake tests and exercise tolerance tests, supporting the use of exercise also in children with inflammatory myopathies, although there are no studies evaluating effects of exercise employed over weeks or months in children. Overall, physical exercise is beneficial, and there is a clear role for adapted physical exercise as additional therapy in the rehabilitation of patients with inflammatory myopathies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexanderson H, Dastmalchi M, Lundberg IE. Patients with chronic inflammatory myopathies have reduced muscle endurance rather than reduced muscle strength. Arthritis Rheum 2006;54(Suppl)1639:S658.
Josefson A, Romanus E, Carlsson J. A functional index in myositis. J Rheumatol 1996;23(8):1380–4.
Wiesinger GF, Quittan M, Nuhr M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000;81(1):1–5.
Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000;27(4):940–8.
Englund P, Nennesmo I, Klareskog L, Lundberg IE. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 2002;46(4):1044–55.
Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 1998;41(3):406–13.
Dastmalchi M, Alexanderson H, Loell I, et al. Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum 2007;57(7):1303–10.
Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998;113(3):407–14.
Nagaraju K, Casciola-Rosen L, Lundberg I, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005;52(6):1824–35.
Askanas V, Engel WK. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol 2007;19(6):550–9.
Warhol MJ, Siegel AJ, Evans WJ, Silverman LM. Skeletal muscle injury and repair in marathon runners after competition. Am J Pathol 1985;118(2):331–9.
Brown JA, Elliott MJ, Sray WA. Exercise-induced upper extremity rhabdomyolysis and myoglobinuria in shipboard military personnel. Mil Med 1994;159(7):473–5.
Ruddy S, Harris ED, Sledge CB, Kelley WN. Kelley’s textbook in rheumatology. 6th ed. Philadelphia: Saunders, 2001.
Hochberg M. Rheumatology. 3rd ed. Edinburgh: Mosby, 2003.
Koopman WJ, Moreland LW. Arthritis and allied conditions; a textbook of rheumatology. 15th ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
Hochberg MC. Rheumatology. 4th ed. Philadelphia: Mosby/Elsevier, 2008.
Hicks JE, Miller F, Plotz P, Chen TH, Gerber L. Isometric exercise increases strength and does not produce sustained creatinine phosphokinase increases in a patient with polymyositis. J Rheumatol 1993;20(8):1399–401.
Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993;20(8):1340-4.
Wiesinger GF, Quittan M, Aringer M, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998;37(2):196–200.
Wiesinger GF, Quittan M, Graninger M, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998;37(12):1338–42.
Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111(2):143–57.
Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999;38(7):608–11.
Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 Health Survey—I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41(10):1349–58.
Heikkila S, Viitanen JV, Kautiainen H, et al. Rehabilitation in myositis: preliminary study. Physiotherapy 2001;87(6):301–9.
Varju C, Petho E, Kutas R, Czirjak L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil 2003;17(1):83–7.
Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007;57(5):768–77.
Miller FW, Rider LG, Chung YL, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001;40(11):1262–73.
Alexanderson H, Broman L, Tollback A, et al. Functional index-2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2006;55(1):114–22.
Rider LG, Giannini EH, Brunner HI, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004;50(7):2281–90.
Paulus HE, Egger MJ, Ward JR, Williams HJ. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis Rheum 1990;33(4):477–84.
Alexanderson H, Lundberg IE, Stenstrom CH. Development of the myositis activities profile—validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol 2002;29(11):2386–92.
Harris-Love MO. Safety and efficacy of submaximal eccentric strength training for a subject with polymyositis. Arthritis Rheum 2005;53(3):471–4.
Alexanderson H, Stenstrom CH, Jenner G, Lundberg I. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 2000;29(5):295–301.
Cea G, Bendahan D, Manners D, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 2002;125(Pt 7):1635–45.
Chung YL, Alexanderson H, Pipitone N, et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;57(4):694–702.
Hurley MV, Scott DL, Rees J, Newham DJ. Sensorimotor changes and functional performance in patients with knee osteoarthritis. Ann Rheum Dis 1997;56(11):641–8.
Gielen S, Adams V, Mobius-Winkler S, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003;42(5):861–8.
Marcora SM, Lemmey AB, Maddison PJ. Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol 2005;32(6):1031–9.
Spector SA, Lemmer JT, Koffman BM, et al. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997;20(10):1242–8.
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(10):1121–3.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14:61–5.
Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med 2003;35(1):31–5.
Felice KJ, Relva GM, Conway SR. Further observations on forearm flexor weakness in inclusion body myositis. Muscle Nerve 1998;21(5):659–61.
Hicks JE, Drinkard B, Summers RM, Rider LG. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002;47(2):118–23.
Takken T, van der Net J, Engelbert RH, Pater S, Helders PJ. Responsiveness of exercise parameters in children with inflammatory myositis. Arthritis Rheum 2008;59(1):59–64.
Takken T, Spermon N, Helders PJ, Prakken AB, Van Der Net J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol 2003;30(5):1075–80.
Takken T, van der Net J, Helders PJ. Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies. Arthritis Rheum 2005;53(2):173–7.
Maillard SM, Jones R, Owens CM, et al. Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis. Arthritis Rheum 2005;53(4):558–64.
Lohmann Siegel K, Hicks JE, Koziol DE, Gerber LH, Rider LG. Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies. Arch Phys Med Rehabil 2004;85(5):767–71.
Alexanderson H. Exercise: an important component of treatment in the idiopathic inflammatory myopathies. Curr Rheum Rep 2005;7:115–24.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Alexanderson, H., Lundberg, I.E. (2009). Muscle Strength and Exercise in Patients with Inflammatory Myopathies. In: Kagen, L. (eds) The Inflammatory Myopathies. Humana Press. https://doi.org/10.1007/978-1-60327-827-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-60327-827-0_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-828-7
Online ISBN: 978-1-60327-827-0
eBook Packages: MedicineMedicine (R0)